Target intelligence / Profile preview

X-ray repair cross-complementing protein 3 (XRCC3)

Target
XRCC3
Molecular classification
Enzyme (DNA repair protein), DNA recombination/repair protein, Member of the RecA/Rad51-related protein family
01

Overview

X-ray repair cross-complementing protein 3 (XRCC3) is a member of the RecA/Rad51-related protein family that is essential for the homologous recombination repair (HRR) pathway of double-stranded DNA, promoting chromosomal stability by repairing DNA damage such as chromosomal fragmentation, translocations, and deletions. XRCC3 acts as a partner within protein complexes (notably, the RAD51 paralog complexes) involved in late stages of homologous recombination, including processing Holliday junctions and maintaining genome integrity. Genetic variations in XRCC3 are associated with altered cancer susceptibility and radiosensitivity. Key distinctions: - XRCC3 is distinct from XRCC1, another DNA repair protein, and is primarily involved in homologous recombination, not single-strand break repair. - There are currently no drugs that directly target XRCC3, but its status in HR pathways makes it relevant to synthetic lethality strategies in cancer therapy.

Other names
XRCC3X-ray repair cross complementing 3DNA repair protein XRCC3
02

Mechanism of action

Not typically a direct drug target, but drugs targeting homologous recombination and DNA repair pathways may indirectly affect XRCC3 function (e.g., synthetic lethality with PARP inhibitors in HR-deficient cancers)

03

Biological functions

Homologous recombination DNA repairMaintenance of chromosome stabilityRepair of DNA double-strand breaksResolution of Holliday junctionsRegulation of mitochondrial DNA copy number under oxidative stress
04

Disease associations

Cancer (e.g., breast cancer, cutaneous malignant melanoma)Genomic instability syndromes
05

Safety considerations

Targeting DNA repair proteins like XRCC3 may lead to increased genomic instability or cytotoxicity in normal cells
06

Biomarkers

Genetic polymorphisms of XRCC3 associated with cancer risk and radiosensitivity

Beyond the preview

Go deeper on X-ray repair cross-complementing protein 3 (XRCC3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-ray repair cross-complementing protein 3 (XRCC3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call